Jörge E. Cortes

机构：Augusta University, University of Alabama at Birmingham, Augusta University Health, National Cancer Center of Georgia, O'Neal Steel (United States) · ORCID：0000-0002-8636-1071

发表论文 3566 篇 · 总被引 145858 次 · h-index 181

代表论文

• Asciminib demonstrates superior efficacy and safety in newly diagnosed chronic myeloid leukemia in the ASC4FIRST trial (2025 · Blood · 被引 12)
• Is there a best frontline therapy in chronic myeloid leukemia? (2025 · Haematologica · 被引 4)
• CPX-351 vs. conventional chemotherapy cardiotoxicity in high-risk AML: a post hoc phase III trial analysis (2025 · Cardio-Oncology · 被引 2)
• Five-year follow-up of OPTIC: long-term efficacy, safety, and mutation analyses of ponatinib in chronic-phase chronic myeloid leukemia from a randomized phase 2 trial (2026 · Leukemia · 被引 1)
• Social determinants drive lymphedema severity and treatment adherence: evidence from a three-year retrospective cohort study (2026 · Supportive Care in Cancer)
• Asciminib monotherapy in patients with BCR::ABL1 T315I-mutated chronic-phase chronic myeloid leukemia: phase 1 trial final results (2026 · Leukemia)